Brief: Somnomed says FY24 Guidance Remains Unchanged
29/10/2023 23:31
Oct 30 (Reuters) - Somnomed Ltd SOM.AX :
* FY24 GUIDANCE REMAINS UNCHANGED
* Q1 FY24 REVENUE OF A$21.4 MILLION UP 15.2% VERSUS PCP
Source text for Eikon: ID:nASX1hM4Jv
Further company coverage: SOM.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on SomnoMed
See all newsAustralia's Somnomed jumps most in 7 months on strong half-year earnings
Brief: Somnomed® Increases Investment In Managed Care Infrastructure
Australia's Somnomed hits 32-month high on upbeat revenue growth
Brief: Somnomed Says Q1 FY26 Revenue Up 13.5% To A$28.7 Million
Brief: Somnomed Says FY EBITDA AUD 9.2 Million